# US 2016/0250335 A1 · Fast disintegrating compositions and tablets thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0250335 A1
- Document ID: US20160250335A1
- Status: Published application
- Kind: A1
- Application number: 15/054,999
- Filed: 2016-02-26
- Published: 2016-09-01
- Earliest claimed: 2015-02-27
- Assignees: Deseret Laboratories, Inc.
- Inventors: Robert F. Dickman; Scott Gubler; Tim Olds; R. Vance Wood; Usha Tuscano; Angel Gonzalez
- Web page: https://patentgrep.com/patent/US20160250335A1

## CPC

- A61K 9/2027: {obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates}
- A61K 9/0056: {Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals}
- A61K 9/2018: {Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Compositions useful for making dosage forms capable of dissolving or disintegrating in less than 10 seconds without the need for conventional disintegrants and methods making and using the same are disclosed.

## Claims

### Claim 1

A rapidly dissolving dosage form, comprising:
(a) a sugar alcohol;
(b) polyvinylpolypyrrolidone;
(c) sodium stearyl fumerate;
(d) an active ingredient.

### Claim 2 (depends on 1)

The dosage form of claim 1, wherein the sugar alcohol is mannitol.

### Claim 3 (depends on 1)

The dosage form of claim 1, wherein the sugar alcohol is present at a concentration of between about 20% to about 80% by weight, the polyvinylpolypyrrolidone is present at a concentration of about 9% to about 60% by weight, the sodium stearyl fumerate is present at a concentration of about 1% to about 30% by weight, and the active ingredient is present at about 10% or less by weight.

### Claim 4 (depends on 1)

The dosage form of claim 1, wherein the dosage dissolves in less than about 10 seconds.

### Claim 5 (depends on 1)

The dosage form of claim 1, wherein the dosage dissolves in less than about 5 seconds.

### Claim 6 (depends on 1)

A method of administering an active ingredient to a patient, comprising providing the dosage form of claim 1 to a patient in need thereof.

### Claim 7

A method of preparing a dosage form, comprising:
providing a sugar alcohol, polyvinylpolypyrrolidone, sodium stearyl fumerate, and an active ingredient; and
compressing the sugar alcohol, polyvinylpolypyrrolidone, sodium stearyl fumerate, and active ingredient.

### Claim 8 (depends on 7)

The method of claim 7, wherein the sugar alcohol is mannitol.

### Claim 9 (depends on 2)

The dosage form of claim 2, wherein the sugar alcohol is present at a concentration of between about 20% to about 80% by weight, the polyvinylpolypyrrolidone is present at a concentration of about 9% to about 60% by weight, the sodium stearyl fumerate is present at a concentration of about 1% to about 30% by weight, and the active ingredient is present at about 10% or less by weight.

### Claim 10 (depends on 9)

The dosage form of claim 9, wherein the dosage dissolves in less than about 10 seconds.

### Claim 11 (depends on 9)

The dosage form of claim 9, wherein the dosage dissolves in less than about 5 seconds.

### Claim 12 (depends on 2)

A method of administering an active ingredient to a patient, comprising providing the dosage form of claim 2 to a patient in need thereof.

### Claim 13 (depends on 3)

A method of administering an active ingredient to a patient, comprising providing the dosage form of claim 3 to a patient in need thereof.

### Claim 14 (depends on 4)

A method of administering an active ingredient to a patient, comprising providing the dosage form of claim 4 to a patient in need thereof.

### Claim 15 (depends on 5)

A method of administering an active ingredient to a patient, comprising providing the dosage form of claim 5 to a patient in need thereof.

### Claim 16 (depends on 9)

A method of administering an active ingredient to a patient, comprising providing the dosage form of claim 9 to a patient in need thereof.

### Claim 17 (depends on 10)

A method of administering an active ingredient to a patient, comprising providing the dosage form of claim 10 to a patient in need thereof.

### Claim 18 (depends on 11)

A method of administering an active ingredient to a patient, comprising providing the dosage form of claim 11 to a patient in need thereof.

### Claim 19 (depends on 12)

A method of administering an active ingredient to a patient, comprising providing the dosage form of claim 12 to a patient in need thereof.
